Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Work In Process (2022 - 2026)

Envoy Medical's Work In Process history spans 5 years, with the latest figure at $50000.0 for Q1 2026.

  • On a quarterly basis, Work In Process fell 7.41% to $50000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $50000.0, a 7.41% decrease, with the full-year FY2025 number at $88000.0, down 56.65% from a year prior.
  • Work In Process hit $50000.0 in Q1 2026 for Envoy Medical, down from $88000.0 in the prior quarter.
  • Over the last five years, Work In Process for COCH hit a ceiling of $203000.0 in Q4 2024 and a floor of $31000.0 in Q3 2023.
  • Historically, Work In Process has averaged $106166.7 across 5 years, with a median of $102500.0 in 2024.
  • Biggest five-year swings in Work In Process: surged 390.32% in 2024 and later crashed 56.65% in 2025.
  • Tracing COCH's Work In Process over 5 years: stood at $164000.0 in 2022, then fell by 3.66% to $158000.0 in 2023, then grew by 28.48% to $203000.0 in 2024, then crashed by 56.65% to $88000.0 in 2025, then tumbled by 43.18% to $50000.0 in 2026.
  • Business Quant data shows Work In Process for COCH at $50000.0 in Q1 2026, $88000.0 in Q4 2025, and $100000.0 in Q3 2025.